Skip to content

Comparison of Usual Care and Distraction (Tablet) in Children 3-5 Years Old

Comparison of Midazolam (Versed) and Distraction on Anxiety, Emergence Delirium, Sedation/Agitation, and Vomiting in Pre-operative Patients Ages 3 to 5.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05368961
Enrollment
137
Registered
2022-05-10
Start date
2017-04-07
Completion date
2019-03-08
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Brief summary

Randomized control trial comparing usual care and distraction (tablet) on anxiety, emergence delirium, sedation/agitation, and vomiting in children 3-5 years old

Detailed description

Two group RCT comparing usual care (midazolam) and distraction (tablet) on preoperative anxiety, emergence delirium, sedation/agitation, and vomiting in preschool children 3-5 years old.

Interventions

BEHAVIORALDistraction

Distraction (interactive tablet)

OTHERUsual care

Anxiolytic ordered by anesthesiologist is usual care

Sponsors

The Cleveland Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Not a blinded study

Intervention model description

Group 1: usual care Group 2: distraction

Eligibility

Sex/Gender
ALL
Age
3 Years to 5 Years
Healthy volunteers
Yes

Inclusion criteria

* 3-5 year old children * Scheduled for elective surgery * American Society of Anesthesiologists physical status classification system: I - II

Exclusion criteria

* Children younger than 3 or older than 6 * Allergy to midazolam * Cognitive or developmental delays * American Society of Anesthesiologists physical status classification system: III - VI * Anesthesia provider determines child is not eligible * Children that are transferred to ICU after surgery

Design outcomes

Primary

MeasureTime frameDescription
mYPAS Anxiety Score, Patients With Scores of 30 or More Indicated AnxietyPre-induction of mask anesthesia in the operating roomPre-operative anxiety measured by the modified Yale Preoperative Anxiety Scale (mYPAS); scores range 23-100 with higher scores indicating greater levels of anxiety. A categorical variable was created using a cut-off score of 30 or more to indicate anxiety and scores of less than 30 indicated no anxiety.

Secondary

MeasureTime frameDescription
Sedation/AgitationPre-induction of mask anesthesia in the operating roomSedation/agitation was assessed using the Richmond Agitation Sedation Scale (RASS) The RASS scale is a 10-item observational tool. Scores on RASS range from negative 5 (unarousable) to positive 4 (combative/violent). For this study, we categorized the RASS scores as agitated, calm, or sedated. Scores of 2 or higher indicated agitation, scores of +1 to -1 were calm, and scores of -2 or lower indicated sedation.
Number of Participants Experiencing Emergence DeliriumAfter surgery when patient woke up in the post anesthesia care unit (recovery room)Postoperatively pediatric patients were assessed for emergence delirium using the Pediatric Anesthesia Emergence Delirium (PAED) tool. The scale uses a 5-point Likert scale with total scores ranging from 0 - 20. This study used a score of 12-20 to indicate the presence of emergence delirium.
Length of Stay (Minutes)Post operative until discharged from post anesthesia care unit (recovery room)Length of stay (total minutes) = time patient admitted to post anesthesia care unit (recovery room) until discharged from post anesthesia care unit.
The Number of Patients Experiencing Postoperative VomitingAfter surgery in the post anesthesia care unit from admission to dischargeThe number of participants that vomited in the post-anesthesia care unit (from the time they were admitted until they were discharged).

Countries

United States

Participant flow

Recruitment details

Children ages 3-5 years were recruited from the pre-operative area at a single surgery site between April 2017 to March 2019.

Participants by arm

ArmCount
Usual Care
Usual care (midazolam) is administered pre-operatively Usual care: Anxiolytic ordered by anesthesiologist is usual care
47
Distraction
Distraction (interactive tablet) is given to children pre-operatively Distraction: Distraction (interactive tablet)
52
Total99

Baseline characteristics

CharacteristicUsual CareDistractionTotal
Age, Categorical
<=18 years
47 Participants52 Participants99 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Customized
3 years old
24 Participants22 Participants46 Participants
Age, Customized
4 years old
16 Participants15 Participants31 Participants
Age, Customized
5 years old
7 Participants15 Participants22 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants3 Participants4 Participants
Race (NIH/OMB)
Black or African American
2 Participants2 Participants4 Participants
Race (NIH/OMB)
More than one race
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants2 Participants6 Participants
Race (NIH/OMB)
White
39 Participants45 Participants84 Participants
Sex: Female, Male
Female
15 Participants24 Participants39 Participants
Sex: Female, Male
Male
32 Participants28 Participants60 Participants
Type of surgery
Ear Nose Throat
20 Participants30 Participants50 Participants
Type of surgery
General Surgery
4 Participants2 Participants6 Participants
Type of surgery
Ophthalmology
13 Participants18 Participants31 Participants
Type of surgery
Urology
10 Participants2 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 470 / 52
other
Total, other adverse events
0 / 470 / 52
serious
Total, serious adverse events
0 / 470 / 52

Outcome results

Primary

mYPAS Anxiety Score, Patients With Scores of 30 or More Indicated Anxiety

Pre-operative anxiety measured by the modified Yale Preoperative Anxiety Scale (mYPAS); scores range 23-100 with higher scores indicating greater levels of anxiety. A categorical variable was created using a cut-off score of 30 or more to indicate anxiety and scores of less than 30 indicated no anxiety.

Time frame: Pre-induction of mask anesthesia in the operating room

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual CaremYPAS Anxiety Score, Patients With Scores of 30 or More Indicated Anxiety20 Participants
DistractionmYPAS Anxiety Score, Patients With Scores of 30 or More Indicated Anxiety22 Participants
p-value: 0.44Wilcoxon (Mann-Whitney)
Secondary

Length of Stay (Minutes)

Length of stay (total minutes) = time patient admitted to post anesthesia care unit (recovery room) until discharged from post anesthesia care unit.

Time frame: Post operative until discharged from post anesthesia care unit (recovery room)

ArmMeasureValue (MEAN)
Usual CareLength of Stay (Minutes)88.0 Minutes
DistractionLength of Stay (Minutes)75.5 Minutes
Secondary

Number of Participants Experiencing Emergence Delirium

Postoperatively pediatric patients were assessed for emergence delirium using the Pediatric Anesthesia Emergence Delirium (PAED) tool. The scale uses a 5-point Likert scale with total scores ranging from 0 - 20. This study used a score of 12-20 to indicate the presence of emergence delirium.

Time frame: After surgery when patient woke up in the post anesthesia care unit (recovery room)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual CareNumber of Participants Experiencing Emergence Delirium7 Participants
DistractionNumber of Participants Experiencing Emergence Delirium8 Participants
Secondary

Sedation/Agitation

Sedation/agitation was assessed using the Richmond Agitation Sedation Scale (RASS) The RASS scale is a 10-item observational tool. Scores on RASS range from negative 5 (unarousable) to positive 4 (combative/violent). For this study, we categorized the RASS scores as agitated, calm, or sedated. Scores of 2 or higher indicated agitation, scores of +1 to -1 were calm, and scores of -2 or lower indicated sedation.

Time frame: Pre-induction of mask anesthesia in the operating room

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Usual CareSedation/AgitationSedated1 Participants
Usual CareSedation/AgitationCalm42 Participants
Usual CareSedation/AgitationAgitated4 Participants
DistractionSedation/AgitationSedated0 Participants
DistractionSedation/AgitationCalm45 Participants
DistractionSedation/AgitationAgitated7 Participants
Secondary

Sedation/Agitation

Sedation/agitation was assessed using the Richmond Agitation Sedation Scale (RASS) The RASS scale is a 10-item observational tool. Scores on RASS range from negative 5 (unarousable) to positive 4 (combative/violent). For this study, we categorized the RASS scores as agitated, calm, or sedated. Scores of 2 or higher indicated agitation, scores of +1 to -1 were calm, and scores of -2 or lower indicated sedation.

Time frame: After surgery at the time of admission to post anesthesia care unit (recovery room)

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Usual CareSedation/AgitationSedated45 Participants
Usual CareSedation/AgitationCalm0 Participants
Usual CareSedation/AgitationAgitated2 Participants
DistractionSedation/AgitationSedated48 Participants
DistractionSedation/AgitationCalm3 Participants
DistractionSedation/AgitationAgitated1 Participants
Secondary

The Number of Patients Experiencing Postoperative Vomiting

The number of participants that vomited in the post-anesthesia care unit (from the time they were admitted until they were discharged).

Time frame: After surgery in the post anesthesia care unit from admission to discharge

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual CareThe Number of Patients Experiencing Postoperative Vomiting1 Participants
DistractionThe Number of Patients Experiencing Postoperative Vomiting2 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026